Abstract:Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to treatment. Despite evidence for the efficacy of multimodality interventions, the majority of persons affected by this disorder do not achieve and sustain full syndromal recovery. It is eagerly anticipated that combining datasets across various information sources (e.g., hierarchical "multi‐omic" measures, electronic health records), analyzed using advanced computational methods (e.g., machine learning), will inform future diagnosis and treatment selection. In the interim, identifying clinically meaningful subgroups of persons with the disorder having differential response to specific treatments at point‐of‐care is an empirical priority. This paper endeavours to synthesize salient domains in the clinical characterization of the adult patient with bipolar disorder, with the overarching aim to improve health outcomes by informing patient management and treatment considerations. Extant data indicate that characterizing select domains in bipolar disorder provides actionable information and guides shared decision making. For example, it is robustly established that the presence of mixed features – especially during depressive episodes – and of physical and psychiatric comorbidities informs illness trajectory, response to treatment, and suicide risk. In addition, early environmental exposures (e.g., sexual and physical abuse, emotional neglect) are highly associated with more complicated illness presentations, inviting the need for developmentally‐oriented and integrated treatment approaches. There have been significant advances in validating subtypes of bipolar disorder (e.g., bipolar I vs. II disorder), particularly in regard to pharmacological interventions. As with other severe mental disorders, social functioning, interpersonal/family relationships and internalized stigma are domains highly relevant to relapse risk, health outcomes, and quality of life. The elevated standardized mortality ratio for completed suicide and suicidal behaviour in bipolar disorder invites the need for characterization of this domain in all patients. The framework of this paper is to describe all the above salient domains, providing a synthesis of extant literature and recommendations for decision support tools and clinical metrics that can be implemented at point‐of‐care.

Longitudinal studies of bipolar patients and their families: translating findings to advance individualized risk prediction, treatment and research

Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention

The Pharmacogenomics of Bipolar Disorder Study (PGBD): Identification of Genes for Lithium Response in a Prospective Sample

Polygenic Burden Analysis of Longitudinal Clusters of Psychopathological Features in A Cross-Diagnostic Group of Individuals with Severe Mental Illness

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

Fine-mapping genomic loci refines bipolar disorder risk genes

THE ROLE OF MICRORNAS IN THE COURSE OF SEVERE MENTAL DISORDERS

Exploring the genetics of lithium response in bipolar disorders

The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives

Progress and Implications from Genetic Studies of Bipolar Disorder

Integrating Polygenic Allele Burden Information and Phenomic Data to Characterize Complex Disease Trajectories in Severe Mental Illness

Putative Risk Biomarkers of Bipolar Disorder in At-risk Youth

Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study

Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings

Common and rare variant analysis in early-onset bipolar disorder vulnerability

Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach

Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers

The Convergence of eQTL Mapping, Heritability Estimation and Polygenic Modeling: Emerging Spectrum of Risk Variation in Bipolar Disorder

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management